✦ LIBER ✦

O-009 Differential effects of gefitinib and cetuximab on EGFR mutant non-small cell lung cancers (NSCLC) cell lines

✍ Scribed by Mukohara, T.; Engelman, J.; Lindeman, N.; Pearlberg, J.; Cantley, L.; Johnson, B.; Jänne, P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMD31 Cost-Effectiveness Analysis of EGF

✍ T. Shiroiwa; Y. Miyoshi; K. Tsutani 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Influence of first-line chemotherapy and

✍ Wu, Jenn-Yu; Yu, Chong-Jen; Shih, Jin-Yuan; Yang, Chih-Hsin; Yang, Pan-Chyr 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 374 KB

Effects of gemcitabine on cell prolifera

✍ E. Pace; M. Melis; L. Siena; F. Bucchieri; A. M. Vignola; M. Profita; M. Gjomark 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 337 KB

O-010 Comparison between clinical non-sm

✍ Ohira, T.; Tsuboi, M.; Hirano, T.; Usuda, J.; Miyajima, K.; Suga, Y.; Honda, H.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB

PCN7 COMPARATIVE EFFECTIVENESS ASSESSMEN

✍ B. Schwander; J. de Castro Carpeño; D.F. Heigener; E. Wright; H.G. Bischoff; S. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

PCN100 COST-EFFECTIVENESS OF GEFITINIB V

✍ J Jacob; M Henriksson; D Brattström 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB